• Measure Summary
  • NQMC:009243
  • 2015 Jul

Proportion of days covered (PDC): percentage of patients who filled at least two prescriptions for a sulfonylurea or sulfonylurea combination on two unique dates of service who met the PDC threshold of 80% during the measurement period.

Pharmacy Quality Alliance

  • Measure Summary
  • NQMC:010707
  • 2016 Jan

Overuse of imaging: ratio of the number of MRI scans to the number of CT scans obtained on or within the 30 days after the date of evaluation for atraumatic headache for children, ages 4 through 17 years old, within the measurement year.

Quality Measurement, Evaluation, Testing, Review, and Implementation Consortium (Q-METRIC)

  • Measure Summary
  • NQMC:010540
  • 2015 Oct

Adherence to antipsychotic medications for individuals with schizophrenia: percentage of members 19 to 64 years of age during the measurement year with schizophrenia who were dispensed and remained on an antipsychotic medication for at least 80 percent of their treatment period.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:010560
  • 2015 Oct
  • NQF-Endorsed Measure

Osteoporosis testing in older women: the percentage of Medicare women 65 to 85 years of age who report ever having received a bone density test to check for osteoporosis.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:010177
  • 2015 Jan
  • NQF-Endorsed Measure

Statin use in persons with diabetes: percentage of patients ages 40 to 75 years who were dispensed a medication for diabetes that receive a statin medication.

Pharmacy Quality Alliance

  • Measure Summary
  • NQMC:010671
  • 2013 Jan

Cancer screening: percentage of women aged 51 to 74 years who have had at least one mammogram performed during the measurement year or the year prior to the measurement year.

The Israel National Program for Quality Indicators in Community Healthcare

  • Measure Summary
  • NQMC:010528
  • 2015 Oct

Statin therapy for patients with diabetes: percentage of members 40 to 75 years of age during the measurement year with diabetes who do not have ASCVD who remained on a statin medication of any intensity for at least 80% of the treatment period.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:009257
  • 2015 Jul

Drug-drug interactions: percentage of patients who received a prescription for a target medication during the measurement period and who were dispensed a concurrent prescription for a precipitant medication.

Pharmacy Quality Alliance

  • Measure Summary
  • NQMC:010773
  • 2016 Jan

Proportion of days covered (PDC): percentage of patients with COPD who filled at least two prescriptions for any long-acting inhaled bronchodilator on two unique dates of service who met the PDC threshold of 80% during the measurement period.

Pharmacy Quality Alliance

  • Measure Summary
  • NQMC:009240
  • 2015 Jul

Proportion of days covered (PDC): percentage of patients who filled at least two prescriptions for a calcium channel blocker (CCB) or CCB combination on two unique dates of service who met the PDC threshold of 80% during the measurement period.

Pharmacy Quality Alliance

  • Measure Summary
  • NQMC:001595
  • 2006 Jun

Diabetes mellitus: percent of patients 40 years and older who have a current prescription for statins.

HRSA Health Disparities Collaboratives: Diabetes Collaborative

  • Measure Summary
  • NQMC:009260
  • 2015 Jul
  • NQF-Endorsed Measure

Antipsychotic use in persons with dementia: percentage of individuals 65 years and older with dementia who are receiving an antipsychotic medication without evidence of a psychotic disorder or related condition.

Pharmacy Quality Alliance

  • Measure Summary
  • NQMC:010542
  • 2015 Oct
  • NQF-Endorsed Measure

Annual monitoring for patients on persistent medications: percentage of members 18 years of age and older who received at least 180 treatment days of ambulatory medication therapy for a select therapeutic agent during the measurement year and at least one therapeutic monitoring event for the therapeutic agent in the measurement year.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:010525
  • 2015 Oct
  • NQF-Endorsed Measure

Comprehensive diabetes care: percentage of members 18 to 75 years of age with diabetes (type 1 and type 2) who received medical attention for nephropathy.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:009128
  • 2013 Jul

Dental care: percentage of children enrolled in two consecutive years who received at least one dental service in both years who received a comprehensive or periodic oral evaluation as a dental service in both years.

Dental Quality Alliance

  • Measure Summary
  • NQMC:009249
  • 2015 Jul

Diabetes medication dosing (DOS): percentage of patients who were dispensed a dose higher than the daily recommended dose for biguanides.

Pharmacy Quality Alliance

  • Measure Summary
  • NQMC:010517
  • 2015 Oct
  • NQF-Endorsed Measure

Persistence of beta-blocker treatment after a heart attack: percentage of members 18 years of age and older during the measurement year who were hospitalized and discharged from July 1 of the year prior to the measurement year to June 30 of the measurement year with a diagnosis of AMI and who received persistent beta-blocker treatment for six months after discharge.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:010878
  • 2016 May

Pediatric asthma: percentage of children, ages 1 through 17 years with persistent asthma, who, during the measurement year, presented to a hospital emergency department (ED) for an asthma exacerbation and were prescribed an inhaled corticosteroid (ICS) at the time of discharge.

Quality Measurement, Evaluation, Testing, Review, and Implementation Consortium (Q-METRIC)

  • Measure Summary
  • NQMC:001604
  • 2006 Jun

Diabetes mellitus: percent of patients 12 to 70 years of age who are not already on angiotensin-converting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB) and have had a microalbuminuria screening test in the last 12 months.

HRSA Health Disparities Collaboratives: Diabetes Collaborative

  • Measure Summary
  • NQMC:010511
  • 2015 Oct

Pharmacotherapy management of COPD exacerbation: percentage of COPD exacerbations for members 40 years of age and older who had an acute inpatient discharge or ED visit on or between January 1 and November 30 of the measurement year and who were dispensed a systemic corticosteroid within 14 days of the event.

National Committee for Quality Assurance